Literature DB >> 17495965

DNA damage check points prevent leukemic transformation in myelodysplastic syndrome.

S Horibe, M Takagi, J Unno, M Nagasawa, T Morio, A Arai, O Miura, M Ohta, M Kitagawa, S Mizutani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17495965     DOI： 10.1038/sj.leu.2404748

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  9 in total

Review 1.  The DNA damage response pathway in normal hematopoiesis and malignancies.

Authors:  Domenico Delia; Shuki Mizutani
Journal:  Int J Hematol       Date:  2017-07-13       Impact factor: 2.490

2.  Single-cell RNA-seq reveals a distinct transcriptome signature of aneuploid hematopoietic cells.

Authors:  Xin Zhao; Shouguo Gao; Zhijie Wu; Sachiko Kajigaya; Xingmin Feng; Qingguo Liu; Danielle M Townsley; James Cooper; Jinguo Chen; Keyvan Keyvanfar; Maria Del Pilar Fernandez Ibanez; Xujing Wang; Neal S Young
Journal:  Blood       Date:  2017-10-13       Impact factor: 22.113

Review 3.  DNA damage response and hematological malignancy.

Authors:  Masatoshi Takagi
Journal:  Int J Hematol       Date:  2017-04-03       Impact factor: 2.490

Review 4.  XCIND as a genetic disease of X-irradiation hypersensitivity and cancer susceptibility.

Authors:  Shuki Mizutani; Masatoshi Takagi
Journal:  Int J Hematol       Date:  2012-12-25       Impact factor: 2.490

5.  Innovative analyses support a role for DNA damage and an aberrant cell cycle in myelodysplastic syndrome pathogenesis.

Authors:  David R Head; James W Jacobberger; Claudio Mosse; Madan Jagasia; William Dupont; Stacey Goodman; Leanne Flye; Andrew Shinar; Sara McClintock-Treep; Greg Stelzer; Robert Briggs; Keith Shults
Journal:  Bone Marrow Res       Date:  2011-06-07

6.  Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasms.

Authors:  Margaret Nieborowska-Skorska; Silvia Maifrede; Yashodhara Dasgupta; Katherine Sullivan; Sylwia Flis; Bac Viet Le; Martyna Solecka; Elizaveta A Belyaeva; Lucia Kubovcakova; Morgan Nawrocki; Martin Kirschner; Huaqing Zhao; Josef T Prchal; Katarzyna Piwocka; Alison R Moliterno; Mariusz Wasik; Steffen Koschmieder; Tony R Green; Radek C Skoda; Tomasz Skorski
Journal:  Blood       Date:  2017-10-17       Impact factor: 25.476

7.  Gene and protein analysis reveals that p53 pathway is functionally inactivated in cytogenetically normal Acute Myeloid Leukemia and Acute Promyelocytic Leukemia.

Authors:  Julia Abramowitz; Tzahi Neuman; Riki Perlman; Dina Ben-Yehuda
Journal:  BMC Med Genomics       Date:  2017-03-24       Impact factor: 3.063

Review 8.  Role of DNA Damage Response in Suppressing Malignant Progression of Chronic Myeloid Leukemia and Polycythemia Vera: Impact of Different Oncogenes.

Authors:  Jan Stetka; Jan Gursky; Julie Liñan Velasquez; Renata Mojzikova; Pavla Vyhlidalova; Lucia Vrablova; Jiri Bartek; Vladimir Divoky
Journal:  Cancers (Basel)       Date:  2020-04-07       Impact factor: 6.639

Review 9.  Bone marrow niches in myeloid neoplasms.

Authors:  Masanobu Kitagawa; Morito Kurata; Iichiroh Onishi; Kouhei Yamamoto
Journal:  Pathol Int       Date:  2019-11-10       Impact factor: 2.534
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.